Gmt Capital Corp Ocugen, Inc. Transaction History
Gmt Capital Corp
- $2.38 Billion
- Q2 2025
A detailed history of Gmt Capital Corp transactions in Ocugen, Inc. stock. As of the latest transaction made, Gmt Capital Corp holds 4,153,798 shares of OCGN stock, worth $4.28 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
4,153,798
Previous 4,153,798
-0.0%
Holding current value
$4.28 Million
Previous $2.95 Million
36.62%
% of portfolio
0.17%
Previous 0.16%
Shares
4 transactions
Others Institutions Holding OCGN
# of Institutions
112Shares Held
64.8MCall Options Held
604KPut Options Held
253K-
Black Rock Inc. New York, NY17.9MShares$18.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.8MShares$15.2 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.06MShares$5.21 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.49MShares$3.59 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X01.73MShares$1.78 Million0.12% of portfolio
About Ocugen, Inc.
- Ticker OCGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,566,000
- Market Cap $223M
- Description
- Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...